Inventor · Albuquerque, NM, US

Christopher Chang

22Patents
7h-index
6Co-inventors
58Inventor score

Filing activity: Aug 20, 2003 → May 29, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US9289418B2 Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens Emerging Cross-Sectional Technologies 43 Active
US6929940B1 Polynucleotides encoding oxalate decarboxylase from Aspergillus niger and methods of use Chemistry; Metallurgy 22 Expired
US9110081B2 Antibody to cytolethal distending toxin of Campylobacter jejuni Emerging Cross-Sectional Technologies 12 Active
US9744208B2 Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens Emerging Cross-Sectional Technologies 10 Active
US9845511B2 Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens Emerging Cross-Sectional Technologies 9 Active
US9851361B2 Methods of comparing anti-vinculin and anti-cytolethal distending toxin antibodies as they relate to irritable bowel syndrome Physics 9 Active
US9869676B2 Antibody to cytolethal distending toxin of Campylobacter jejuni Emerging Cross-Sectional Technologies 9 Active
US10132814B2 Methods for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease Physics 6 Active
US10151752B2 Antibody to cytolethal distending toxin of Campylobacter jejuni Emerging Cross-Sectional Technologies 6 Active
US10226505B2 Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens Emerging Cross-Sectional Technologies 5 Active
US10688149B2 Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens Emerging Cross-Sectional Technologies 3 Active
US11235022B2 Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens Emerging Cross-Sectional Technologies 2 Active
US10527621B2 Antibody to cytolethal distending toxin of Campylobacter jejuni Emerging Cross-Sectional Technologies 2 Active
US9952223B2 Method for detecting anti-vinculin antibodies in a subject with an IBS symptom Physics 2 Active
US10466254B2 Method of measuring a level of anti-vinculin antibodies in a biological sample Physics 2 Active
US10690679B2 Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease Physics 2 Active
US9702884B2 Methods for detecting the presence of irritable bowel syndrome and system for diagnosing same Physics 2 Active
US10519515B2 Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens Emerging Cross-Sectional Technologies 1 Active
US10352944B2 Method of determinig levels of anti-vinculin and anti-cytolethal distending toxin antibodies in subjects desiring to distinguish irritable bowel syndrome from inflammatory bowel disease Physics 1 Active
US10988570B2 Molecules and oligomers for endothermic singlet fission Chemistry; Metallurgy 0 Active
US12071673B2 Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens Emerging Cross-Sectional Technologies 0 Active
US11693009B2 Methods for detecting post-infectious irritable bowel syndrome Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.